WVE

7.59

2.71% 0.20

Dopo l'orario di chiusura: 7.56 -0.03 -0.40%

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$7.39

Aprire:

$7.48

Volume 24 ore:

3.45M

Relative Volume:

0.83

Capitalizzazione di mercato:

$1.43B

Reddito:

$42.73M

Utile/perdita netta:

$-204.38M

Rapporto P/E:

-6.2603

EPS:

-1.2124

Flusso di cassa netto:

$-189.73M

1 W Prestazione:

+6.90%

1M Prestazione:

-41.71%

6M Prestazione:

-6.18%

1 anno Prestazione:

+20.86%

Intervallo 1D:

$7.30

$7.74

Intervallo di 1 settimana:

$6.97

$7.74

Portata 52W:

$5.02

$21.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1112)

Industria

Biotechnology (621)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

317

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2025-03-04

Ultimi documenti SEC

WVE's Discussions on Twitter

Compare WVE vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE Wave Life Sciences Ltd	7.59	1.39B	42.73M	-204.38M	-189.73M	-1.2124
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-05	Iniziato	BofA Securities	Buy
2025-12-12	Reiterato	Wedbush	Outperform
2025-12-09	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2025-10-20	Iniziato	Wells Fargo	Overweight
2025-08-04	Iniziato	Canaccord Genuity	Buy
2025-07-28	Iniziato	Oppenheimer	Outperform
2025-07-16	Iniziato	Citigroup	Buy
2025-06-11	Ripresa	Raymond James	Outperform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-08	Iniziato	Wedbush	Outperform
2025-02-25	Iniziato	Jefferies	Buy
2024-10-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

04:34 AM

Wave Life Sciences plans redomicile from Singapore to U.S. - Investing.com

04:34 AM

04:32 AM

Wave Life Sciences Plans Redomiciling to Delaware Corporation - TipRanks

04:32 AM

04:13 AM

Wave Life Sciences plans redomicile from Singapore to U.S. By Investing.com - Investing.com Canada

04:13 AM

04:08 AM

Wave Life Sciences (Nasdaq: WVE) sets tax-free U.S. redomiciliation - Stock Titan

04:08 AM

04:01 AM

Wave Life Sciences seeks Delaware move to cut compliance costs - Stock Titan

04:01 AM

Apr 14, 2026

Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - MSN

Apr 14, 2026

WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowe - GuruFocus

Apr 14, 2026

WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowered to $18 - GuruFocus

Apr 14, 2026

Wave Life Sciences (WVE) price target decreased by 20.34% to 28.29 - MSN

Apr 14, 2026

Apr 12, 2026

RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE) - Yahoo Finance

Apr 12, 2026

Apr 10, 2026

Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Apr 10, 2026

WVE Stock Price, Quote & Chart | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill

Apr 10, 2026

Apr 09, 2026

Wave Life Sciences plunges after early-stage data for obesity therapy - MSN

Apr 09, 2026

Apr 08, 2026

Wave Life Sciences Ltd. R (1U5.DU) Q1 FY2025 earnings call transcript - Yahoo Finance

Apr 08, 2026

Apr 07, 2026

RBC Capital Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $15 - Moomoo

Apr 07, 2026

RBC Capital Adjusts Wave Life Sciences PT to $15 From $27, Maintains Outperform Rating - Moomoo

Apr 07, 2026